Kevin B. Givechian,Chad Garner,Hermes J. Garban,Shahrooz Rabizadeh,Patrick Soon-Shiong
申请号：
US16264379
公开号：
US20190233900A1
申请日:
2019.01.31
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Compositions, methods, and uses of de novo pyrimidine synthesis pathway element, CAD, and optionally a second gene in a nucleotide excision repair pathway, POLD2 in determining a predicted survival rate, predicted responsiveness to a cisplatin-based chemotherapy of a patient diagnosed with bladder urothelial carcinoma are provided.
